乙酸乙酯

Search documents
百傲化学上半年净利同比下降
Zhong Guo Hua Gong Bao· 2025-09-23 02:38
Core Viewpoint - Dalian Baiao Chemical Co., Ltd. reported a revenue of 749 million yuan for the first half of 2025, marking a year-on-year increase of 28.42%, while net profit decreased by 44.22% to 91.79 million yuan [1] Group 1: Financial Performance - The company achieved a revenue of 749 million yuan, reflecting a growth of 28.42% compared to the previous year [1] - Net profit for the first half of the year was 91.79 million yuan, which represents a decline of 44.22% year-on-year [1] Group 2: Business Segments - Baiao Chemical has established a dual business model focusing on industrial biocides and semiconductor equipment [1] - The chemical business is facing challenges due to external environmental factors, weak market demand, and continuously low prices, leading to sustained pressure on profitability [1] - The semiconductor business is part of a long-term strategic plan aimed at technology accumulation and building a competitive advantage [1] Group 3: Market Trends - Despite the overall pressure on the biocide business, positive changes are emerging, with the average sales price of biocide products increasing by 7.69% quarter-on-quarter [1] - The comprehensive procurement cost of key raw materials, including n-octylamine, methyl acrylate, magnesium nitrate, ethyl acetate, and chlorine, decreased by 21.37% quarter-on-quarter [1] - The gross margin of the industrial biocide business is expected to improve on a quarter-on-quarter basis [1]
百傲化学(603360) - 大连百傲化学股份有限公司关于2025年第二季度主要经营数据的公告
2025-08-28 10:21
证券代码:603360 证券简称:百傲化学 公告编号:2025-060 大连百傲化学股份有限公司 关于 2025 年第二季度主要经营数据的公告 公司 2025 年第二季度正辛胺、丙烯酸甲酯、硝酸镁、乙酸乙酯、氯气等主 要原材料综合采购成本环比下降 21.37%,同比上升 13.59%。 三、其他对公司生产经营具有重大影响的事项 本季度内公司未发生对生产经营具有重大影响的其他事项。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 根据上海证券交易所《上市公司自律监管指引第 3 号——行业信息披露第十 三号——化工》等规定的要求,大连百傲化学股份有限公司(以下简称"公司") 将 2025 年第二季度主要经营数据披露如下: 一、主要产品的产量、销量及收入实现情况 | 主要产品 | 2025 | 年第二季度 | 2025 年第二季度 | | 2025 年第二季度 | | --- | --- | --- | --- | --- | --- | | | | 产量(吨) | 销量(吨) | | 销售收入(万元) | | 工业杀菌剂 | | ...
宇新股份:公司拥有一套10万吨/年丁酮联产6.5万吨/年乙醇装置
Zheng Quan Ri Bao Zhi Sheng· 2025-07-31 12:12
Core Viewpoint - Company is expanding its production capacity for ketone and ethanol, indicating growth potential in its operations [1] Group 1: Company Operations - Company currently operates a facility with an annual production capacity of 100,000 tons of ketone and 65,000 tons of ethanol [1] - Company is in the process of constructing a project to expand its ketone and ethyl acetate production capacity, which will increase ketone production capacity to 150,000 tons per year upon completion [1] - The expansion project is currently in the stages of approval and equipment procurement [1]
宇新股份:丁酮联产乙酸乙酯扩能项目将使丁酮产能提升至15万吨/年
Jin Rong Jie· 2025-07-31 01:37
Core Viewpoint - The company is expanding its production capacity for ketone and ethanol due to rising prices and market demand following Shell's closure of its ketone production [1] Group 1: Company Information - The company currently operates a production facility with an annual capacity of 100,000 tons of ketone and 65,000 tons of ethanol [1] - An expansion project for ketone and ethyl acetate production is underway, which will increase the ketone capacity to 150,000 tons per year [1] - The expansion project is currently in the approval and equipment procurement stages [1] Group 2: Market Context - The price of ketone has surged from 6,400 yuan per ton in June to 8,400 yuan per ton, marking an increase of over 30% [1]
宇新股份(002986) - 2025年5月7日投资者关系活动记录表
2025-05-07 09:48
Group 1: Financial Performance - The company achieved an operating income of 7.701 billion yuan in 2024, a year-on-year increase of 16.51% [10] - The net profit attributable to shareholders was 307.05 million yuan, a decrease of 32.34% compared to the previous year [10] - The net cash flow from operating activities was 154 million yuan, down 77.14% year-on-year [10] - Total assets at the end of the period reached 7.990 billion yuan, an increase of 24.22% [10] - Net assets attributable to shareholders were 4.043 billion yuan, up 7.55% year-on-year [10] Group 2: Research and Development - R&D expenses in 2024 amounted to 304 million yuan, a 24.93% increase from 243 million yuan in 2023 [3] - R&D investment decreased by 6.92% year-on-year, raising concerns about maintaining technological leadership [3] - The company focuses on new technologies and products related to its main business, including catalyst development and new process innovations [6] Group 3: Project Developments - A 240,000 tons/year maleic anhydride facility was completed and put into operation in April 2025 [4] - Ongoing projects include the first and second phases of the light hydrocarbon comprehensive utilization project and the expansion of maleic anhydride production [4] - The company plans to construct a 200,000 tons/year isopropyl acetate facility, expected to be operational in Q4 2025 [4] Group 4: Market Strategy and Challenges - The company aims to expand its market share by focusing on high value-added, high-tech deep processing products [5] - The green and low-carbon transformation in the chemical industry presents challenges such as increased environmental pressure and urgent innovation needs [4] - The company is diversifying its overseas markets to mitigate risks associated with international trade tensions [8] Group 5: Long-term Goals - The company has set a target to achieve over 1 million tons of capacity, 10 billion yuan in output value, and 10 billion yuan in revenue by 2025 [8] - Future strategies include expanding the carbon four industrial chain and focusing on high-end chemical products [6]